Serial Number
88514434
Owner
Sarepta Therapeutics, Inc.Attorney
Paul C. LlewellynFirst Use Date
Jul 12, 2012
Filing Date
Jul 15, 2019
Serial #88514434 Trademark
Serial Number: 88514434 • Registration: 6342347
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Paul C. Llewellyn ARNOLD & PORTER KAYE SCHOLER LLP
250 West 55th Street
New York, NY 10019-9710
UNITED STATES
Trademark Details
Filing Date
July 15, 2019
Registration Date
May 4, 2021
First Use Anywhere
July 12, 2012
First Use in Commerce
October 15, 2014
Published for Opposition
February 25, 2020
Goods & Services
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
